J E Berchuck
Overview
Explore the profile of J E Berchuck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
47
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goyal L, DiToro D, Facchinetti F, Martin E, Peng P, Baiev I, et al.
Ann Oncol
. 2024 Dec;
PMID: 39706336
Background: Fibroblast growth factor receptor (FGFR) inhibitors have significantly improved outcomes for patients with FGFR-altered cholangiocarcinoma, leading to their regulatory approval in multiple countries. As with many targeted therapies, however,...
2.
McGregor B, Sonpavde G, Kwak L, Regan M, Gao X, Hvidsten H, et al.
Ann Oncol
. 2023 Oct;
35(1):91-97.
PMID: 37871703
Background: The antibody-drug conjugates sacituzumab govitecan (SG) and enfortumab vedotin (EV) are standard monotherapies for metastatic urothelial carcinoma (mUC). Given the different targets and payloads, we evaluated the safety and...
3.
Berchuck J, Facchinetti F, DiToro D, Baiev I, Majeed U, Reyes S, et al.
Ann Oncol
. 2022 Sep;
33(12):1269-1283.
PMID: 36089135
Background: Targeted therapies have transformed clinical management of advanced biliary tract cancer (BTC). Cell-free DNA (cfDNA) analysis is an attractive approach for cancer genomic profiling that overcomes many limitations of...